Clinical Trial Update: Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing an immune-guided cytomegalovirus prevention strategy to universal prophylaxis in kidney transplant recipients; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Snippet

Sponsor: University Hospital, Rouen | Conditions: Kidney Transplant Infection | Phase 3 | Status: RECRUITING